Literature DB >> 19400606

Different aspects of psoriasis: analysis of 150 Iranian patients.

Maryam Moghaddassi1, Farhad Shahram, Cheyda Chams-Davatchi, Seyed-Reza Najafizadeh, Fereydoun Davatchi.   

Abstract

BACKGROUND: Psoriatic arthritis is defined as an inflammatory arthritis associated with psoriasis and is classified as a seronegative HLA-B27-associated spondyloarthropathy. We aimed to study the clinical and paraclinical presentations of psoriatic arthritis in 150 Iranian patients.
METHODS: Demographic, clinical, and paraclinical data obtained from 150 patients enrolled in a retro- and introspective study were analyzed.
RESULTS: The female:male ratio was 1.11:1. The mean age at the onset of arthritis was 33.3 years. Arthritis occurred after psoriasis in 73%, preceded it in 17%, and simultaneously in 10% of the patients. The patterns of joint involvement were asymmetric oligoarthritis (46%), polyarthritis (5%), axial involvement (16%), distal interphalangeal joint involvement (23%), and mutilating arthritis (2.2%). There was no correlation between distal interphalangeal joint involvement and nail disease (P=0.33). Polyarthritis was more common in women (P=0.03) and axial involvement was more in men (P=0.02). Patients with spondylitis were younger at the disease onset (P<0.02). Dactylitis was seen in 12% of the patients. Enthesopathy (20.7%) was more common in patients with axial involvement (P=0.008) and joint deformity (15%) was more common in patients with polyarthritis or distal interphalangeal joint involvement (P<0.0002). Four patients had ocular inflammation. Anemia was detected in 24%, high erythrocyte sedimentation rate in 79%, and abnormal urinary indices in 9% of the patients. There was a significant correlation between HLA-B27 (16%) and axial involvement (P=0.01) as well as joint erosions (16%) and distal interphalangeal joint involvement (P<0.0001). Thirty-four patients (26.8%) showed radiographic findings of sacroiliitis, while only 14 of them had axial involvement.
CONCLUSION: Oligoarthritis was the most common type of joint involvement in these Iranian patients. We found no correlation between distal interphalangeal joint involvement and nail changes, although it was seen with more erosive changes and joint deformity. In comparison with other studies, extra-articular manifestations were not common in our patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19400606

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  4 in total

1.  Rheumatology training and research in Iran.

Authors:  Alireza Khabbazi; Mohsen Soroosh
Journal:  Rheumatol Int       Date:  2019-05-20       Impact factor: 2.631

Review 2.  The perspective on psoriatic arthritis in Asia.

Authors:  Ying-Ying Leung; Lai-Shan Tam; Edmund K Li
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

Review 3.  Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis.

Authors:  Sueli Carneiro; Penelope Esther Palominos; Sônia Maria Alvarenga Anti; Rodrigo Luppino Assad; Rafaela Silva Guimarães Gonçalves; Adriano Chiereghin; Andre Marun Lyrio; Antônio Carlos Ximenes; Carla Gonçalves Saad; Célio Roberto Gonçalves; Charles Lubianca Kohem; Cláudia Diniz Lopes Marques; Cláudia Goldenstein Schainberg; Eduardo de Souza Meirelles; Gustavo Gomes Resende; Lenise Brandao Pieruccetti; Mauro Waldemar Keiserman; Michel Alexandre Yazbek; Percival Degrava Sampaio-Barros; Ricardo da Cruz Lage; Rubens Bonfiglioli; Thauana Luíza Oliveira; Valderílio Feijó Azevedo; Washington Alves Bianchi; Wanderley Marques Bernardo; Ricardo Dos Santos Simões; Marcelo de Medeiros Pinheiro; Cristiano Barbosa Campanholo
Journal:  Adv Rheumatol       Date:  2021-11-24

4.  Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.

Authors:  Dafna D Gladman; Philip J Mease; Paul Bird; Enrique R Soriano; Soumya D Chakravarty; May Shawi; Stephen Xu; Sean T Quinn; Cinty Gong; Evan Leibowitz; Denis Poddubnyy; Lai-Shan Tam; Philip S Helliwell; Arthur Kavanaugh; Atul Deodhar; Mikkel Østergaard; Xenofon Baraliakos
Journal:  Trials       Date:  2022-09-05       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.